Basic Chemical and Chemical Product Manufacturing
ANZSIC subdivision 18 · 39 mergers
Since January 2026, the ACCC has reviewed 39 acquisitions in the Basic Chemical and Chemical Product Manufacturing industry (ANZSIC subdivision 18): 25 notified mergers and 14 waiver applications. Of these, 1 was referred to Phase 2. Outcomes so far: 34 approved, 3 not approved and 2 still under assessment. The most frequent acquirers are Eli Lilly (6), Parker-Hannifin (2) and Henkel (2). Completed Phase 1 reviews took a median of 17 business days, and waivers a median of 18 business days. The most recent, Sun Pharma - Organon, was lodged on 22 October 2026.
Total reviews
39
Phase 2 reviews
1
Waivers
14
Under assessment
2
Sub-industries
Mergers in this industry
- Sun Pharma - OrganonUnder assessment
- Zoetis – Neogen Genomics BusinessUnder assessment
- Koch – 50% interest in certain assets of OCP NutricropsApproved
- Built Living joint venture – Human UrbanApproved
- Kirin – Jamieson WellnessApproved
- Macquarie Korea Asset Management – Hwasung Cosmetics and NowcosApproved
- Northpharm Services - Wesley Pharmacy GroupApproved
- Olin - HuntsmanApproved
- Merck KGaA–Bio-TechneApproved
- Eli Lilly – Merida BiosciencesApproved
- Lone Star Funds - ContiTechApproved
- Kirin – Jamieson WellnessNot approved
- Novonesis – MicrobiogenApproved
- Saint-Gobain - XypexApproved
- Supagas – Heeson MedicalApproved
- Triton – United InitiatorsApproved
- Wesfarmers and Built Group - Built Living Joint VentureApproved
- Eli Lilly - AtaiBeckley Inc.Approved
- Movac – Advanced NavigationApproved
- Petalite – EnvuApproved
- AbbVie - ApogeeApproved
- Vertex – CrineticsApproved
- Apollo - Bayer Asset ManagementApproved
- Parker-Hannifin – CIRCOR A&DApproved
- Apollo Capital – CuriaApproved
- WHP Global and G-III - Marc JacobsApproved
- CVC Capital Partners and Groupe Bruxelles Lambert – RecordatiApproved
- Henkel – OlaplexApproved
- Eli Lilly - Kelonia TherapeuticsApproved
- Gilead - OuroApproved
- Eli Lilly – acquisition of licence from CSL BehringApproved
- Mayfair Corporation – Phosphate HillApproved
- Francisco Partners - Blackline SafetyApproved
- Eli Lilly - Orna TherapeuticsApproved
- CVC Capital Partners – Marathon Asset ManagementApproved
- Gilead - ArcellxApproved
- Eli Lilly – Orna TherapeuticsNot approved
- Parker-Hannifin – Filtration GroupApproved
- Henkel – ATP adhesive systems groupNot approved